Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKB | Q96GD4 | 2/20 | 0.67 |
| ▸ | AURKA | O14965 | 1/20 | 0.67 |
| ▸ | COMT | P21964 | 1/20 | 0.53 |
| ▸ | TTR | P02766 | 2/20 | 0.52 |
| ▸ | ATIC | P31939 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NSD2 | O96028 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | IDE | P14735 | 1/20 | 0.44 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.44 |
| ▸ | CCR6 | P51684 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 2/20 | 0.44 |
| ▸ | LDHA | P00338 | 1/20 | 0.44 |
| ▸ | SNCA | P37840 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12919700 | 0.94 | AURKB (0.74) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL29817449 | 0.90 | AURKB (0.74) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL1413174 | 0.90 | AURKB (0.74) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL10903980 | 0.89 | AURKB (0.72) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL10361623 | 0.89 | AURKB (0.62) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL28065859 | 0.86 | ATIC (0.57) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL11431250 | 0.84 | AURKA (0.66) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL1805338 | 0.84 | AURKA (0.49) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL3211377 | 0.84 | AURKB (0.87) | AURKBAURKACOMTTTRATIC | |
| SCHEMBL11350582 | 0.83 | MEN1 (0.50) | AURKBAURKACOMTTTRATIC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070275221-A1 | NEAR-INFRARED ABSORPTION FILM | BRIDGESTONE CORPORATION | 2007-11-29 | — | — | US | claimed |
| US-6805718-B2 | USING AROMATIC AMINE, NAPHTHOL OR AMINONAPHTHALENE AND ENZYME | NOVOZYMES A/S (DK) | 2004-10-19 | — | — | US | claimed |
| US-20040184173-A1 | Near-infrared absorption film | BRIDGESTONE CORPORATION | 2004-09-23 | — | — | US | claimed |
| US-20030226215-A1 | Enzymatic method for textile dying | NOVOZYMES NORTH AMERICA, INC. (US) | 2003-12-11 | — | — | US | claimed |
| WO-2003016615-A1 | SINGLE BATH PROCESS FOR BLEACHING AND DYEING TEXTILES | NOVOZYMES NORTH AMERICA, INC. (US) | 2003-02-27 | — | — | WO | claimed |
| EP-1266068-A1 | ENZYMATIC METHOD FOR TEXTILE DYEING | Novozymes North America, Inc. (US) | 2002-12-18 | — | — | EP | claimed |
| US-20010037532-A1 | Enzymatic method for textile dyeing | NOVOZYMES A/S (DK) | 2001-11-08 | — | — | US | claimed |
| US-6296672-B1 | PEROXIDASE, OXIDOREDUCTASE, LACCASE | NOVOZYMES A/S PATENTS (DK) | 2001-10-02 | — | — | US | claimed |
| WO-2001044563-A1 | ENZYMATIC METHOD FOR TEXTILE DYEING | NOVOZYMES NORTH AMERICA, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| US-6036729-A | DYEING, SOAKING MATERIAL WITH NAPHTHOLS, HYDROGEN PEROXIDE AND ENZYMES OF PEROXIDASE OR OXIDASE | NOVO NORDISK A/S (DK) | 2000-03-14 | — | — | US | claimed |
| WO-1995022641-A1 | FLUX FOR REFLOWING TINPLATE | LEARONAL, INC. (US) | 1995-08-24 | — | — | WO | claimed |
| US-5427677-A | Using a naphthalenesulfonic acid | LEARONAL, INC. (US) | 1995-06-27 | — | — | US | claimed |
| US-20250333472-A1 | Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto | GEORGE MASON RES FOUNDATION INC (US) | 2025-10-30 | — | — | US | disclosed |
| EP-4574815-A1 | PROCESS FOR THE SEPARATION OF AROMATIC SULPHONIC ACIDS AND SALTS FROM AQUEOUS PHASES | Saltigo GmbH (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-12331096-B2 | Binding domain mapping and compounds, compositions, complexes, methods, and kits related thereto | George Mason Research Foundation, Inc. (US) | 2025-06-17 | — | — | US | disclosed |
| CN-107207751-B | Shrink films comprising NIR absorbing coatings and methods of making the same | 陶氏环球技术有限责任公司 | 2020-12-25 | — | — | CN | disclosed |
| US-4126609-A | AZO DYESTUFF WITH A FIBER-REACTIVE GROUP ATTACHED TO A NAPHTHALENE SULPHONIC ACID COMPONENT | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-21 | — | — | US | disclosed |
| US-4124531-A | Catalytic composite for the treatment of sour petroleum distillates | UOP INC. (US) | 1978-11-07 | — | — | US | disclosed |
| US-4121998-A | Treating a petroleum distillate with a supported metal phthalocyanine and a polynuclear aromatic sulfonic acid | UOP INC. (US) | 1978-10-24 | — | — | US | disclosed |
| US-4049704-A | AZO REACTIVE DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250333472-A1 | Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto | SNRPE, SSBP1, RPA1 | AURKB 1915/4885AURKA 3644/4885COMT 3355/4885 |
| US-12331096-B2 | Binding domain mapping and compounds, compositions, complexes, methods, and kits related thereto | SNRPE, SSBP1, RPA1 | AURKB 1915/4885AURKA 3644/4885COMT 3355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.